| Methods |
RCT comparing lamifiban versus placebo in patients with acute coronary syndrome. |
| Data |
Of 5225 patients enrolled, 5163 were analysed (2568/2595, respectively in each treatment group). |
| Comparisons |
Onsite assessment (local investigator blinded) versus assessment by an AC blinded to allocated treatment. |
| Outcomes |
The primary selected was a composite outcome myocardial infarction, ischaemia or death at 30 days. This was the study's primary outcome. |
| Notes |
|
| Risk of bias |
| Item |
Authors' judgement |
Description |
| Method for selecting cases to adjudicate? |
No |
All suspect events adjudicated were identified through a computer algorithm. |
